Butterfly Network Insiders File Form 144 to Sell 1.7 Million Shares
1h ago|4 min readStandard
Fazen Markets Editorial Desk
Collective editorial team · methodology
butterfly-networkform-144
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD 24/5 on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. Vortex HFT is informational software — not investment advice. Past performance does not guarantee future results.
Corporate insiders at Butterfly Network, Inc. filed a Form 144 with the SEC on June 5, 2026, announcing their intent to sell a combined 1.7 million shares of company stock. The planned disposition, submitted by several officers and directors, represents a material percentage of their collective holdings. This filing follows a period of sustained downward pressure on the handheld ultrasound technology company's share price, which has declined over 28% year-to-date.
Insider selling activity is closely monitored as a potential signal of management's confidence in near-term prospects. The June 5 filing arrives during a challenging period for the medical device sector, with the iShares U.S. Medical Devices ETF (IHI) facing headwinds from prolonged sales cycles and hospital budget constraints. The specific timing of this coordinated filing suggests the shares recently became eligible for sale after the expiration of a lock-up period following a previous corporate action or award vesting schedule.
The volume of shares proposed for sale is significant relative to average trading volumes. Butterfly Network's stock has an average 30-day trading volume of approximately 1.2 million shares. A sale of 1.7 million shares could therefore represent more than a full day's worth of market activity, potentially creating temporary selling pressure. The last major insider sale event occurred in Q4 2025, when a director sold 500,000 shares, after which the stock declined 9% over the subsequent month.
The Form 144 filing specifies an aggregate total of 1,700,000 Class A common shares slated for potential sale. Based on Butterfly Network's closing price of $1.15 on June 4, the intended sale has a notional value of approximately $1.96 million. This planned activity contrasts sharply with the company's market capitalization, which stands near $230 million.
Butterfly Network's stock performance provides critical context for the filing. The share price has fallen 28.4% since the start of 2026. This significantly underperforms the broader healthcare sector, with the Health Care Select Sector SPDR Fund (XLV) showing a modest gain of 3.1% over the same period. The company's 52-week range is wide, from a low of $0.89 to a high of $1.98, highlighting its volatility.
| Metric | Before Filing (June 4 Close) | YTD Change |
|---|---|---|
| Share Price | $1.15 | -28.4% |
| 30-Day Avg. Volume | 1.2M shares | -5% |
| Market Cap | ~$230M | -$90M |
The selling group includes multiple officers, though the filing does not always break down individual allocations. This scale of insider selling is atypical for the company, which has seen only sporadic, smaller filings over the past 12 months.
The immediate market impact is likely concentrated on Butterfly Network's stock (BFLY), where liquidity is not deep enough to easily absorb the proposed sale without a price concession. Market makers may widen bid-ask spreads in anticipation of the transaction. This event could also cast a pall over small-cap medical technology peers like Shockwave Medical (SWAV) and iRhythm Technologies (IRTC), as investors may scrutinize those companies for similar insider behavior, though their fundamentals are distinct.
A counter-argument is that insider sales are often pre-scheduled for personal financial planning, such as tax payments or diversification, and do not necessarily reflect a negative outlook on the business. However, the collective and sizable nature of this filing makes it difficult to dismiss entirely as routine. Trading flow data indicates a recent increase in short interest in BFLY, which now stands at 8.5% of the float, suggesting some institutional players are positioning for further downside.
The key near-term catalyst is the actual execution of the sales disclosed in the Form 144. Investors should monitor daily trading volumes and SEC Form 4 filings, which will report the exact prices and dates of each transaction once they occur. These filings typically follow the Form 144 within days or weeks.
Butterfly Network's next earnings report, expected around August 6, 2026, will be critical for assessing whether operational performance can offset the negative sentiment from insider selling. Key metrics to watch include revenue growth for the Butterfly iQ+ device and the company's updated full-year guidance. Technically, the stock faces resistance at the $1.25 level, a previous support zone that may now act as a ceiling; a break below the recent $1.05 support could signal a test of the 52-week low.
A Form 144 is a mandatory notice filed with the SEC when corporate insiders—such as officers, directors, or major shareholders—intend to sell restricted or control securities. The form declares their plan to sell but does not guarantee the sale will happen. It is required for sales of shares exceeding 5,000 units or having a value over $50,000 in any three-month period, providing transparency into potential changes in insider ownership.
The 1.7 million-share filing is notably larger than Butterfly Network's typical insider sales. Over the past year, the largest individual sale was 500,000 shares. The aggregate size of this filing suggests a coordinated exit by multiple insiders, which is less common than isolated, individual sales and often attracts greater market scrutiny due to the implied consensus among management.
For retail investors, large-scale insider selling is a data point that warrants attention but not panic. It signals that those with the most intimate knowledge of the company's challenges are reducing their exposure. Retail investors should review the company's fundamental health, including cash flow and product demand, rather than reacting solely to the filing. Diversification remains a key defense against volatility triggered by such events.
The scale of the planned insider sale intensifies existing skepticism around Butterfly Network's near-term stock performance.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
Vortex HFT is our free MT4/MT5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. Trades 24/5.
Position yourself for the macro moves discussed above
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.